Apogee Therapeutics Earnings Estimate
| APGE Stock | 62.36 0.12 0.19% |
Apogee Therapeutics Earnings Estimation Breakdown
The calculation of Apogee Therapeutics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Apogee Therapeutics is estimated to be -1.1281 with the future projection ranging from a low of -1.2261 to a high of -1.0185. Please be aware that this consensus of annual earnings estimates for Apogee Therapeutics Common is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.23 Lowest | Expected EPS | -1.02 Highest |
Apogee Therapeutics Earnings Projection Consensus
Suppose the current estimates of Apogee Therapeutics' value are higher than the current market price of the Apogee Therapeutics stock. In this case, investors may conclude that Apogee Therapeutics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Apogee Therapeutics' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 16 | 60.71% | 0.0 | -1.1281 | -4.38 |
Apogee Therapeutics Earnings per Share Projection vs Actual
Actual Earning per Share of Apogee Therapeutics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Apogee Therapeutics Common predict the company's earnings will be in the future. The higher the earnings per share of Apogee Therapeutics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Apogee Therapeutics Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Apogee Therapeutics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Apogee Therapeutics should always be considered in relation to other companies to make a more educated investment decision.Apogee Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Apogee Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-11-10 | 2025-09-30 | -0.61 | -1.11 | -0.5 | 81 | ||
2025-08-11 | 2025-06-30 | -0.62 | -1.13 | -0.51 | 82 | ||
2025-05-12 | 2025-03-31 | -0.58 | -0.95 | -0.37 | 63 | ||
2025-03-03 | 2024-12-31 | -0.62 | -1.18 | -0.56 | 90 | ||
2024-11-13 | 2024-09-30 | -0.56 | -0.8631 | -0.3031 | 54 | ||
2024-08-12 | 2024-06-30 | -0.52 | -0.6 | -0.08 | 15 | ||
2024-05-13 | 2024-03-31 | -0.61 | -0.64 | -0.03 | 4 | ||
2024-03-05 | 2023-12-31 | -0.49 | -0.32 | 0.17 | 34 | ||
2023-11-13 | 2023-09-30 | -0.41 | -0.51 | -0.1 | 24 | ||
2023-08-28 | 2023-06-30 | -1.7 | -3.78 | -2.08 | 122 | ||
2023-05-31 | 2023-03-31 | 0 | -2.38 | -2.38 | 0 |
About Apogee Therapeutics Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Apogee Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Apogee Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Apogee Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -275.3 M | -261.6 M | |
| Earnings Yield | (0.08) | (0.09) | |
| Price Earnings Ratio | (12.35) | (12.97) | |
| Price Earnings To Growth Ratio | (0.14) | (0.13) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Apogee Therapeutics is a strong investment it is important to analyze Apogee Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apogee Therapeutics' future performance. For an informed investment choice regarding Apogee Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apogee Therapeutics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Biotechnology sector continue expanding? Could Apogee diversify its offerings? Factors like these will boost the valuation of Apogee Therapeutics. If investors know Apogee will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Apogee Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Apogee Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Apogee Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Apogee Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Apogee Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Apogee Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Apogee Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.